<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04062292</url>
  </required_header>
  <id_info>
    <org_study_id>GO 19/665</org_study_id>
    <nct_id>NCT04062292</nct_id>
  </id_info>
  <brief_title>Gait Parameters and Balance in Patients With Obstructive Lung Diseases</brief_title>
  <official_title>Investigation of Gait Parameters and Balance in Patients With Obstructive Lung Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hacettepe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hacettepe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the literature, most of the studies examining the gait characteristics and balance&#xD;
      separately or examining the relationship between them are on patients with COPD.&#xD;
&#xD;
      No study examining gait parameters in other obstructive pulmonary patients such as&#xD;
      bronchiectasis and asthma was found.A convincing link between gait disturbances and falls in&#xD;
      COPD patients is still unknown and further research is needed. Therefore, the purpose of our&#xD;
      study; gait parameters and balance in individuals with obstructive pulmonary disease. We will&#xD;
      also examine the relationship between gait parameters and extrapulmonary clinical indicators&#xD;
      of these individuals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with COPD call walking as one of the most problematic activities in daily life.&#xD;
      Patients with COPD walk less in daily life than their healthy peers. Gait characteristics of&#xD;
      extrapulmonary comorbidities that probably affect the musculoskeletal and cardiovascular&#xD;
      system vary. The gait assessment gives an idea about the biomechanical factors associated&#xD;
      with a reduction in walking distance in COPD patients. In patients with COPD, after the onset&#xD;
      of shortness of breath or leg fatigue, a decrease in cadence during walking, shortened stride&#xD;
      length, an increase in the time spent in the double support period, an increase in the peak&#xD;
      ankle dorsi flexion moment is observed. During gait, there is an increase in balance&#xD;
      disorders in the mediolateral direction. In addition, patients with COPD walk on a constant&#xD;
      speed treadmill with more stride time and less step width variability. Studies have shown&#xD;
      that patients with COPD have increased temporal walking characteristics, decreased step and&#xD;
      stride length, and increased walking variability.&#xD;
&#xD;
      In the literature, most of the studies that examine gait characteristics and balance&#xD;
      separately or examine the relationship between them are on patients with COPD. No study&#xD;
      examining gait parameters in other obstructive pulmonary patients such as bronchiectasis and&#xD;
      asthma has been found. A persuasive link between walking disorders and falls in COPD patients&#xD;
      is still unknown and further research is needed. This study will contribute to clarifying the&#xD;
      mechanisms of why the balance studied in patients with COPD is adversely affected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 29, 2021</start_date>
  <completion_date type="Anticipated">December 8, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 8, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Gait parameters</measure>
    <time_frame>01.09.2020-08.07.2021</time_frame>
    <description>Gait parameters will be assessed with Biodex Gait Trainer (Biodex Medical Systems, Shirley, New York) for six minutes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Balance and Fall Risk</measure>
    <time_frame>01.09.2020-08.07.2021</time_frame>
    <description>Timed Up and Go Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Exercise Capacity</measure>
    <time_frame>01.09.2020-08.07.2021</time_frame>
    <description>6 minute walking test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Muscle Strength</measure>
    <time_frame>01.09.2020-08.07.2021</time_frame>
    <description>Respiratory muscle strength parameters (maximal inspiratory and maximal expiratory pressure) measurement using mouth pressure device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral Muscle Strength</measure>
    <time_frame>01.09.2020-08.07.2021</time_frame>
    <description>Muscle strength of the knee extensors, hip extensors, shoulder abductors, trunk flexors and trunk extensors will be evaluated by hand dynamometer (Lafayette Manual Muscle Tester Model 01165-USA). Jamar Hand Dynamometer (USA) will measure the hand grip force</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities of Daily Living</measure>
    <time_frame>01.09.2020-08.07.2021</time_frame>
    <description>Glittre-ADL test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Status</measure>
    <time_frame>01.09.2020-08.07.2021</time_frame>
    <description>Mini Mental Test</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Gait Disorder, Sensorimotor</condition>
  <arm_group>
    <arm_group_label>Obstructive lung diseases group</arm_group_label>
    <description>Having been diagnosed with obstructive pulmonary disease,&#xD;
No acute exacerbation or infection in the past 1 week, Being between the ages of 18 and 65,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy group</arm_group_label>
    <description>Age and sex matched healthy subjects without orthopedic and chronic diseases</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The obstructive lung diseases from every subgroups: COPD, asthma and bronchiectasis&#xD;
        patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for Obstructive Lung Diseases&#xD;
&#xD;
          1. Being diagnosed with obstructive lung disease,&#xD;
&#xD;
          2. Have not experienced acute exacerbation or infection in the last 1 week,&#xD;
&#xD;
          3. To be between 18-65 years,&#xD;
&#xD;
          4. Volunteering for research,&#xD;
&#xD;
          5. To be able to walk and cooperate.&#xD;
&#xD;
        Exclusion Criteria for Obstructive Lung Diseases:&#xD;
&#xD;
          1. Use walking aid or be chronic oxygen support&#xD;
&#xD;
          2. To have orthopedic or neuromuscular comorbidities that may affect walking patterns.&#xD;
&#xD;
          3. Having had lung cancer, sarcoidosis, tuberculosis disease or lung surgery.&#xD;
&#xD;
        Inclusion Criteria for Healthy People 1.18-65 years of age, 2. Volunteer to participate in&#xD;
        the research, 3. To be able to walk and cooperate.&#xD;
&#xD;
        Exclusion Criteria for Healthy People&#xD;
&#xD;
          1. Having any cardiopulmonary disease,&#xD;
&#xD;
          2. To have an advanced orthopedic disease that may affect functional capacity measurement&#xD;
             and gait patterns.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naciye Vardar-Yagli, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Naciye Vardar-Yagli, PhD</last_name>
    <phone>+903123051576</phone>
    <phone_ext>123</phone_ext>
    <email>naciyevardar@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Naciye Vardar-Yagli</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naciye Vardar-Yagli, PhD</last_name>
      <phone>+903123051576</phone>
      <phone_ext>123</phone_ext>
      <email>naciyevardar@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Melda Saglam, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ebru Calik-Kutukcu, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Deniz Inal-Ince, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 15, 2019</study_first_submitted>
  <study_first_submitted_qc>August 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2019</study_first_posted>
  <last_update_submitted>January 29, 2021</last_update_submitted>
  <last_update_submitted_qc>January 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hacettepe University</investigator_affiliation>
    <investigator_full_name>Naciye Vardar-Yagli</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>balance</keyword>
  <keyword>chronic obstructive diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Gait Disorders, Neurologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

